This update covers grant activity from July - September, 2020.
Our Theory of Change
How We Measure Success
Our Country, Regional and Fellowship Scheme Grants are evaluated by an independent evaluator, Itad using the following six evaluation questions. Each question is measured against a specific framework that helps quantify Fleming Fund’s contribution and impact.
- What has been the increase in the quality and/or quality of data on AMR at country level and to what extent has the Fleming Fund contributed to this increase?
- To what extent have the Fleming Fund investments been aligned and coherent with other relevant investments at a country level?
- How likely are the Fleming Fund country level results to be sustained?
- Has or is it likely that the increase in AMR data included a) changes in the national polices/regulations and or b) changes in practices and attitudes in the country?
- What has been the increase in quality data shared and reported internationally and has the Fleming Fund contributed to this?
- Did the Fleming Fund investment at a country level offer Value for Money?
How We Measure Laboratory Capacity Building
Strengthening surveillance systems and laboratory capacity are the primary activities of the Fleming Fund, and our Country, Regional and Fellowship Scheme grants support over 200 laboratories worldwide with training, resourcing and renovations.
To measure how well we are building capacity, we use a framework developed by the London School of Hygiene and Tropical Medicine, AMR Surveillance in Low and Middle Income Countries, initially published in 2016.
The framework, also funded by Fleming, was developed by over 30 international AMR experts including microbiologists, infectious disease experts and epidemiologists and outlines several critical competencies for laboratories. Competency examples include data management & analysis, quality assurance mechanisms, isolate storage and transport and bacterial culture, identification and susceptibility testing.
Proficiency in these competencies helps laboratories generate, share and use AMR data better. Locally AMR data can help clinicians make better decisions for patient care; nationally, data can be used to guide health policy; and internationally, AMR data can provide early warnings of emerging threats.
Programme Update Bulletin: Quarter 3, 2020
Programme Update Bulletin: Quarter 2, 2020
This update covers grant activity from April - June, 2020.